同型半胱氨酸调控FOXO3a介导线粒体损伤在代谢相关脂肪性肝病中的作用OA
Homocysteine regulates FOXO3a to mediate mitochondrial damage in metabolism-associated fatty liver disease
目的 探讨同型半胱氨酸(Hcy)调控 FOXO3a 介导线粒体损伤在代谢相关脂肪性肝病(MAFLD)中的影响及其作用机制.方法 将 6 周龄Cbs+/-小鼠(n=12)随机分为 2 组,普通饲料喂养 12 周设为饮食对照(ND)组,高蛋氨酸饲料喂养 12 周设为高蛋氨酸饮食(HMD)组.CCK-8 试剂盒检测不同浓度(0、50、100、150 μmol/L)Hcy 处理后肝细胞的抑制率;体外培养 NCTC1469 小鼠正常肝细胞,分为正常对照(Control)组、Hcy干预(100 μmol/L Hcy,Hcy)组、转染干扰片段对照(si-NC)组、转染FOXO3a干扰片段(si-FOXO3a)组、Hcy干预下干扰片段对照(Hcy+si-NC)组和Hcy干预下FOXO3a干扰片段(Hcy+si-FOXO3a)组.HE染色观察肝组织损伤;油红O染色观察肝细胞内脂滴的分布及蓄积程度;总胆固醇(TC)和甘油三酯(TG)分析细胞内脂质代谢产物的含量;Western blot检测小鼠肝脏组织(ND组和HMD组)和肝细胞(Control组和Hcy组)中FOXO3a蛋白表达差异;ROS观察细胞内氧化应激程度;JC-1 检测线粒体膜电位;Mito-tracker观察线粒体的形态改变;RT-qPCR检测各分组mtDNA表达变化.结果 与ND组相比,HMD组肝组织结构紊乱,肝细胞肿大,胞质疏松淡染,细胞内见大量空泡样变及脂滴沉积;与Control组相比,Hcy组肝细胞内油红O阳性脂滴数量增多,TC、TG水平升高(P<0.001);与ND组、Control组相比,HMD组、Hcy组中FOXO3a蛋白表达显著增高(P<0.05);与Hcy+si-NC组相比,Hcy+si-FOXO3a组细胞内ROS水平降低,JC-1 单体显著减少(P<0.01),线粒体碎裂减少,mtDNA表达水平降低(P<0.01),细胞内油红O阳性脂滴数量减少,TC、TG水平降低(P<0.001).结论 FOXO3a通过调控线粒体损伤在Hcy引起的MAFLD脂质代谢紊乱中起重要促进作用.
Objective To investigate the effects and mechanism of homocysteine(Hcy)-regulated FOXO3a-mediated mitochondrial damage in metabolic dysfunction-associated fatty liver disease(MAFLD).Methods Six-week-old Cbs+/-mice(n=12)were divided randomly into two groups and fed a normal diet group(ND group)or a high-methionine diet group(HMD group),respectively,for 12 weeks(n=6 mice per group).The inhibition rate of hepatocytes after treatment with different concentrations(0、50、100、150 μmol/L)of Hcy was detected by the Cell Counting Kit-8 Kit.NCTC1469 normal mouse hepatocytes were divided into the following groups:Control group,Hcy intervention group(Hcy group,100 μmol/L Hcy),negative control(NC)small interfering(si)RNA-transfected group(si-NC group),FOXO3a siRNA-transfected group(si-FOXO3a group),NC siRNA-transfected with Hcy intervention group(Hcy+si-NC group),and FOXO3a siRNA-transfected with Hcy intervention group(Hcy+si-FOXO3a group).Liver tissue injury was observed by HE staining and the distribution and accumulation of lipid droplets in hepatocytes was detected by Oil Red O staining.Total cholesterol(TC)and triglycerides(TG)were analyzed to indicate the lipid metabolite contents of the cells.FOXO3a protein expression in liver tissues(ND group and HMD group)and liver cells(Control group and Hcy group)were detected by Western blot.Reactive oxygen species(ROS)were measured to indicate the degree of oxidative stress in cells.Mitochondrial membrane potential was detected using JC-1 and morphological changes in mitochondria were observed using Mito-tracker.Changes in mtDNA expression were detected by quantitative reverse transcription-polymerase chain reaction.Results Liver tissue structure was disordered in the HMD group compared with the ND group,hepatocytes were enlarged,the cytoplasm was loose and lightly stained,and a large number of vacuoles and lipid droplets were observed in the liver cells.The number of Oil Red O-positive lipid droplets was increased in the Hcy group compared with the Control group,and TC and TG levels were increased(P<0.001).Expression levels of FOXO3a protein were significantly increased in the HMD group and Hcy group compared with the ND group and Control group(P<0.05).Intracellular ROS levels were decreased in the Hcy+si-FOXO3a group compared with the Hcy+si-NC group,and JC-1 monomer,mitochondrial fragmentation,mtDNA expression level,the number of Oil Red O-positive lipid droplets,and TC level and TG level were also all decreased(P<0.01,P<0.001).Conclusions FOXO3a plays an important promoting role in lipid metabolic disorders of MAFLD caused by Hcy by regulating mitochondrial damage.
焦运;姜怡邓;张婕;刘惠娟;杨佳琪;王雅菁;刘虹麟;马芳;李桂忠;张慧萍
宁夏医科大学总医院感染科,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004宁夏医科大学总医院医学实验中心,银川 750004宁夏医科大学总医院感染科,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004国家卫生健康委员会代谢性心血管疾病研究重点实验室,银川 750004湖南省妇幼保健院,长沙 410028
医药卫生
FOXO3a线粒体HcyMAFLD
FOXO3amitochondriaHcyMAFLD
《中国比较医学杂志》 2026 (3)
36-45,10
国家自然科学基金项目(82460120)宁夏自然科学基金项目(2024AAC03592)宁夏医科大学校级重点项目(XJKF240311)癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项(2024ZD0531200)宁夏回族自治区重点研发计划重点项目(2023BEG02074)湖南省卫生健康高层次人才重大科研专项(R2023120).
评论